BARCELONA — The future looks bright for the ophthalmic industry, which currently enjoys a very favorable trend, according to one speaker at the Ophthalmology Futures European Forum.The ophthalmology market attracts investors, according to Brian Scullian, managing director and partner at William Blair & Company, the global investment banking and wealth management firm that acted as sell-side advisor to Synergetics in its sale to Valeant.
When Doctors Get Sick: How Much to Share About Mental Illness?
(MedPage Today) — Mental health professionals with their own issues face a dilemma
BioTime Announces Dual Listing on the Tel Aviv Stock Exchange
ALAMEDA, Calif. & TEL AVIV, Israel–(BUSINESS WIRE)–BioTime, Inc. (NYSE MKT: BTX), a biotechnology company focused on the development and commercialization of cell-based therapies, announced today that the Tel Aviv Stock Exchange (TASE) has approved the new listing of BioTime’s common shares beginning on Tuesday, September 8, 2015 under the ticker symbol BTX. Based on the current market capitalization, BioTime’s shares are anticipated to be included in five TASE equity indexes: TASE’s TA-75, T
Research and Markets: Global Glaucoma Treatment Market – Trends And Opportunities: 2015 Edition
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/h46cbq/global_glaucoma) has announced the addition of the “Global Glaucoma Treatment Market – Trends And Opportunities: 2015 Edition” report to their offering. Th…
SalutarisMD receives FDA clearance for radionuclide brachytherapy source
BARCELONA — Salutaris Medical Devices has received 510(k) clearance from FDA for its SMD Sr90-1 radionuclide brachytherapy source, according to a press release.The treatment is indicated for episcleral brachytherapy of tumors and benign growths for use within a manual brachytherapy applicator system, the release said.
Sindrome dell’occhio secco: un Simposio Internazionale promosso da Dompé sulle nuove prospettive in ricerca per i bisogni non soddisfatti dei pazienti
BARCELLONA, Spagna–(BUSINESS WIRE)–Arrossamento e irritazione agli occhi, prurito e bruciore, vista annebbiata, sensazione di un corpo estraneo nella palpebra. Sono solo alcuni dei più comuni sintomi che caratterizzano la sindrome dell’occhio secco, una condizione sempre più diffusa a causa di fattori ambientali ma anche per comportamenti e stili di vita che portano a trascurare l’importanza di una corretta lubrificazione oculare. La patologia, spesso sottovalutata ma che può avere ripercussi